Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

Cellebrite DI ( ($CLBT) ) just unveiled an announcement. On August 15, 2025, Cellebrite DI Ltd. announced its upcoming Annual General Meeting of ...

Cellebrite DI ( (CLBT) ) has provided an update. Cellebrite DI Ltd. has released its unaudited consolidated financial statements for the six months ending June 30, 2025, showing a significant ...

Cellebrite experienced solid growth in Q2 2025, exceeding expectations for sales and earnings. Signs of a rebound are encouraging.

Detailed price information for Cellebrite Di Ltd (CLBT-Q) from The Globe and Mail including charting and trades.

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Cellebrite DI Ltd. (NASDAQ:CLBT) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 25, Cellebrite DI Ltd.

For comparison, CLBT has a P/B of 11.34. These metrics, and several others, help SMGZY earn a Value grade of B, while CLBT has been given a Value grade of D. Both SMGZY and CLBT are impressive stocks ...

In a remarkable display of market confidence, shares of CLBT have surged to an all-time high, touching a price level of $24.21.

In recent trading, shares of Cellebrite DI Ltd (Symbol: CLBT) have crossed above the average analyst 12-month target price of $23.29, changing hands for $23.87/share. When a stock reaches the ...

Cellebrite DI has come under pressure after an allegation that its tech was used for unethical practices in Serbia. The company’s phone unlocking technology was used to install home-grown ...